Jolanda van der Velden

17.7k citations

270 papers · 11.4k indexed · 2 hit papers · h-index 57

Cardiology and Cardiovascular Medicine top 0.1%
- Cardiomyopathy and Myosin Studies 189
- Cardiovascular Function and Risk Factors 99
- Cardiovascular Effects of Exercise 86
- Cardiac electrophysiology and arrhythmias 42
- Viral Infections and Immunology Research 30
Molecular Biology top 1%
- Congenital heart defects research 25
- Muscle Physiology and Disorders 21
- Ion channel regulation and function 15
Endocrinology, Diabetes and Metabolism top 2%
Cancer Research top 5%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Ger J.M. Stienen Walter J. Paulus Attila Borbély Jean G.F. Bronzwaer Nazha Hamdani Diederik W.D. Kuster Cristobal G. dos Remedios Vasco Sequeira
Cited by: Cardiology and Cardiovascular Medicine Molecular Biology Endocrinology, Diabetes and Metabolism
Journals: Journal of Molecular and Cellular Cardiology (21 papers)Cardiovascular Research (19 papers)Circulation Research (13 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Jolanda van der Velden

262 papers receiving 11.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Jolanda van der Velden

Since Specialization

Citations

This map shows the geographic impact of Jolanda van der Velden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanda van der Velden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanda van der Velden more than expected).

Fields of papers citing papers by Jolanda van der Velden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanda van der Velden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanda van der Velden. The network helps show where Jolanda van der Velden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jolanda van der Velden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jolanda van der Velden Line = papers co-authored together Jolanda van der Velden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Experimental Models of Hypertrophic Cardiomyopathy JACC Basic to Translational Science ·Ajay G. Pise,Zan Crowder,Khaled H. Hosny,Chantal Remy-Ferraro,Anni Eskild-Jensen,Forrest C Ward,Joselyne Nicole,Ebtisam Mohammed Taki Salman,Linda Schoonmade,Jolanda van der Velden,Birgit Goversen	2025	2
2	Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models EMBO Molecular Medicine ·Anni Eskild-Jensen,G. Ottinger,Mirjam Langeveld,Clara D.M. van Karnebeek,Jolanda van der Velden,Riekelt H. Houtkooper,Signe Mosegaard	2025	0
3	Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in preclinical individuals with an HCM sarcomeric gene mutation European Heart Journal ·M.M. Hudert,貞三高沢,María-T Gálvez-Mercado,Roy Huurman,M. Patricia Juárez,Ashit Pathak,王暁斐,Tjeerd Germans,Michelle Michels,Jolanda van der Velden	2024	1
4	Translating metabolic and cardiovascular research into effective treatments: What’s next? Cell ·Juleen R. Zierath,Jolanda van der Velden,Ali Javaheri,Anthony Rosenzweig,Deborah M. Muoio,Erin E. Mulvihill,Tami A. Martino,Adil Rasheed,Xiaowei Chen,Zoltàn Arany	2024	1
5	Chronic Activation of Tubulin Tyrosination Improves Heart Function Circulation Research ·Yuli Supodo,Christina Y. Chen,Sanjay Deori,Lucas Bacmeister,Birgit Geertz,Marisol Herrera-Rivero,Bekkali G.J.,丁希洲,Elisabeth Krämer,Ingke Braren,Dirk Westermann,Hartmut Schlüter,Giulia Mearini,Saskia Schlossarek,Jolanda van der Velden,Matthew A. Caporizzo,Diana Lindner,Benjamin L. Prosser,Lucie Carrier	2024	8
6	Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy Circulation Genomic and Precision Medicine ·D. Stolf,Maike Schuldt,Vasco Sequeira,Aleksandra Binek,Thang V. Pham,貞三高沢,M. Jansen,Bauke V. Schomakers,Michel van Weeghel,Frédéric M. Vaz,Riekelt H. Houtkooper,Jennifer E. Van Eyk,Connie R. Jiménez,Michelle Michels,Kenneth Bedi,Kenneth B. Margulies,Cristobal G. dos Remedios,Diederik W.D. Kuster,Jolanda van der Velden	2024	8
7	Insight in the (Phospho)proteome of Vascular Smooth Muscle Cells Derived From Patients With Abdominal Aortic Aneurysm Reveals Novel Disease Mechanisms Arteriosclerosis Thrombosis and Vascular Biology ·贾东友,文俊竹田津,Alex A. Henneman,Jaco C. Knol,Thang V. Pham,Sander R. Piersma,Connie R. Jiménez,Natalija Bogunovic,Jolanda van der Velden,Kak Khee Yeung	2024	2
8	Sarcomere disassembly and transfection efficiency in proliferating human iPSC-derived cardiomyocytes European Heart Journal ·Qing‐Song Yuan,E. Klingmuller,E. Brouwer,Joost P. G. Sluijter,Jolanda van der Velden,Dan Dan Fan	2023	1
9	Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers Journal of Cardiovascular Translational Research ·M. Jansen,Amand F. Schmidt,Judith Jans,Imke Christiaans,Saskia N. van der Crabben,Yvonne M. Hoedemaekers,Dennis Dooijes,Jan D.H. Jongbloed,Kunkun Shan,Ronald H. Lekanne Deprez,Arthur A.M. Wilde,Jolanda van der Velden,Rudolf A. de Boer,J. Peter van Tintelen,Folkert W. Asselbergs,Annette F. Baas	2023	4
10	EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy Circulation Research ·J W HANKINS,Maike Schuldt,Emmy Manders,友美沢崎,Saskia Schlossarek,Richard de Goeij-de Haas,Alex A. Henneman,Sander R. Piersma,Connie R. Jiménez,Michelle Michels,Lucie Carrier,Michiel Helmes,Jolanda van der Velden,Diederik W.D. Kuster	2023	13
11	Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants International Journal of Molecular Sciences ·M. Jansen,Maike Schuldt,Megha Koduri,Amand F. Schmidt,Imke Christiaans,Saskia N. van der Crabben,Yvonne M. Hoedemaekers,Dennis Dooijes,Jan D.H. Jongbloed,Ludolf G. Boven,Ronald H. Lekanne Deprez,Arthur A.M. Wilde,Judith Jans,Jolanda van der Velden,Rudolf A. de Boer,J. Peter van Tintelen,Folkert W. Asselbergs,Annette F. Baas	2023	9
12	Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy Frontiers in Cardiovascular Medicine ·Matteo Camurri,Snehal Raj,明丸山,Julia Beck,R N Hunston,Tim Holler,Priyanka Kumari,П А Деменков,André Zeug,Denise Hilfiker‐Kleiner,Cristobal G. dos Remedios,Jolanda van der Velden,Judith Montag,Theresia Kraft	2022	2
13	Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy Circulation Heart Failure ·Tim R. Eijgenraam,Cornelis J. Boogerd,Στυλιανός Σφακιωτάκης,G. Proft,Martin M. Dokter,Lukas Schmidt,Xiaoke Yin,Konstantinos Theofilatos,Manuel Mayr,Peter van der Meer,Eva van Rooij,Jolanda van der Velden,Herman H.W. Silljé,Rudolf A. de Boer	2021	24
14	Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes STAR Protocols ·Renée G. C. Maas,Soah Lee,Magdaléna Harakaľová,雄平松原,William R. Goodyer,Jesper Hjortnaes,Pieter A. Doevendans,Linda W. van Laake,Jolanda van der Velden,Folkert W. Asselbergs,Joseph C. Wu,Joost P. G. Sluijter,Sean M. Wu,Jan W. Buikema	2021	34
15	Cellular, mitochondrial and molecular alterations associate with early left ventricular diastolic dysfunction in a porcine model of diabetic metabolic derangement Scientific Reports ·Ilkka Heinonen,Oana Sorop,Bas M. van Dalen,Rob C. I. Wüst,Jens van de Wouw,Vincent J. de Beer,Yanti Octavia,Richard W. B. van Duin,Youri Hoogstrate,Lau Blonden,Olexandr-Zenoviy Mirus,Katja Anttila,Andrew Stubbs,Jolanda van der Velden,Daphne Merkus,Dirk J. Duncker	2020	15
16	Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle The Journal of Physiology ·Kelly Stam,Geoff Renshaw,Jakub Stemberk,Richard W. B. van Duin,Erdoğan ALKİN,Jolanda van der Velden,Alexander Hirsch,Dirk J. Duncker,Daphne Merkus	2019	13
17	Right ventricular oxygen delivery as a determinant of right ventricular functional reserve during exercise in juvenile swine with chronic pulmonary hypertension American Journal of Physiology-Heart and Circulatory Physiology ·Geoff Renshaw,Richard W. B. van Duin,Kelly Stam,André Uitterdijk,Jolanda van der Velden,Anton Vonk Noordegraaf,Dirk J. Duncker,Daphne Merkus	2019	3
18	Carriers of the Hypertrophic Cardiomyopathy MYBPC3 Mutation are Characterized by Reduced Myocardial Efficiency in the Absence of Hypertrophy and Microvascular Dysfunction European Journal of Heart Failure ·Stefan A.J. Timmer,Tjeerd Germans,Wessel P. Brouwer,Mark Lubberink,Jolanda van der Velden,Arthur A.M. Wilde,Imke Christiaans,Adriaan A. Lammertsma,Paul Knaapen,Albert C. van Rossum	2011	48
19	Diastolic Stiffness of the Failing Diabetic Heartbreakdown → Circulation ·Loek van Heerebeek,Nazha Hamdani,M. Louis Handoko,Inês Falcão‐Pires,René J.P. Musters,Koba Kupreishvili,Alexander Ijsselmuiden,Casper G. Schalkwijk,Jean G.F. Bronzwaer,Michaëla Diamant,Attila Borbély,Jolanda van der Velden,Ger J.M. Stienen,Gerrit J. Laarman,Hans W.M. Niessen,Walter J. Paulus	2007	556
20	Abstract 3156: Protein Kinase G Corrects High Cardiomyocyte Resting Tension in Diastolic Heart Failure Circulation ·Nazha Hamdani,Attila Borbély,Nicky M. Boontje,István Édes,Inês Falcão‐Pires,Adelino Leite‐Moreira,Ger J.M. Stienen,Jolanda van der Velden,Walter J. Paulus	2007	2

About Jolanda van der Velden

Jolanda van der Velden is a scholar working on Cardiology and Cardiovascular Medicine, Medical Terminology and Molecular Biology, having authored 270 papers that have together received 11.4k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (189 papers), Cardiovascular Function and Risk Factors (99 papers), Cardiovascular Effects of Exercise (86 papers), Cardiac electrophysiology and arrhythmias (42 papers), Viral Infections and Immunology Research (30 papers), Congenital heart defects research (25 papers), Muscle Physiology and Disorders (21 papers) and Ion channel regulation and function (15 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.7k citations), Molecular Biology (4.3k citations) and Endocrinology, Diabetes and Metabolism (627 citations). Jolanda van der Velden has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ger J.M. Stienen, Walter J. Paulus, Attila Borbély, Jean G.F. Bronzwaer, Nazha Hamdani, Diederik W.D. Kuster, Cristobal G. dos Remedios, Vasco Sequeira, Hans W.M. Niessen and Loek van Heerebeek. Their work appears in journals such as Journal of Molecular and Cellular Cardiology, Cardiovascular Research, Circulation Research, Circulation and Journal of Muscle Research and Cell Motility.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact